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Abstract
Editing domains of aminoacyl tRNA synthetases correct tRNA charging errors to maintain 
translational fidelity. A mutation in the editing domain of alanyl tRNA synthetase (AlaRS) in 
Aarssti mutant mice resulted in an increased production of serine-mischarged tRNAAla and 
degeneration of cerebellar Purkinje cells. By positional cloning, we identified Ankrd16, which acts 
epistatically with the Aarssti mutation to attenuate neurodegeneration. ANKRD16, a vertebrate-
specific, ankyrin repeat-containing protein, binds directly to the catalytic domain of AlaRS. Serine 
misactivated by AlaRS is captured by lysine side chains of ANKRD16, preventing the charging of 
serine adenylates to tRNAAla and precluding serine misincorporation in nascent peptides. Deletion 
of Ankrd16 in the Aarssti/sti brain causes widespread protein aggregation and neuron loss. These 
results identify a novel amino acid-accepting co-regulator of tRNA synthetase editing as a new 
layer of the machinery essential for preventing severe pathologies that arise from defects in 
editing.
Accurate aminoacylation of tRNAs by tRNA synthetases establishes the universal genetic 
code and occurs in two steps: first, activation of the selected amino acid with ATP to form an 
aminoacyl adenylate; second, transfer of the aminoacyl group of the adenylate to the 2’- or 
3’-OH of the cognate tRNA. However, structural similarities between some amino acids 
allow misactivation of non-cognate amino acids and subsequent misacylation of tRNA. 
These errors can be corrected by the hydrolytic editing functions found in many tRNA 
synthetases 1, 2. ‘Editing’ can occur after amino acid misactivation, but prior to aminoacyl 
transfer, or after aminoacylation of tRNA, known as pre-transfer and post-transfer editing, 
respectively. Pre-transfer editing occurs in either the aminoacylation active site or in a 
distinct editing site, whereas post-transfer editing occurs only in the editing site of these 
enzymes 3, 4, 5.
The importance of tRNA synthetase editing including editing by the alanyl tRNA synthetase 
(Aars; AlaRS) has been shown in multiple organisms 6, 7, 8, 9, 10, 11. Although AlaRS 
misactivates both glycine and serine, misactivation of serine appears to have more serious 
consequences, perhaps due to the presence of D-aminoacyl-tRNA deacylases which act on 
Gly-tRNAAla 12, 13, 14. We previously showed that sticky (sti) mutant mice that have a point 
mutation (Ala734Glu) in the editing domain of AlaRS have ubiquitinated protein aggregates 
in cerebellar Purkinje cells and subsequent degeneration of these neurons 9. The sti mutation 
results in only a 2-fold increase in the generation of Ser-tRNAAla, demonstrating that 
Purkinje cells are particularly sensitive to loss of AlaRS editing 9.
Here we identified a novel vertebrate-specific gene Ankrd16 that greatly attenuates 
misfolded aggregate formation and Purkinje cell degeneration in Aarssti/sti mice. Deletion of 
Ankrd16 in other Aarssti/sti neurons also caused formation of ubiquitinated protein 
aggregates and neuron death. ANKRD16 binds to AlaRS and prevents misincorporation of 
serine at alanine codons in nascent peptides by stimulating serine-dependent ATP hydrolysis 
prior to tRNA aminoacylation via acceptance of misactivated serines. Our data collectively 
reveal ANKRD16 as a co-regulator of AlaRS that protects against assaults on translation 
fidelity and proteostasis in mammalian neurons.
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Results
Ankrd16 suppresses Aarssti-mediated Purkinje cell degeneration
Aarssti/sti mice on the inbred C57BL/6J (B6) genetic background are ataxic with cerebellar 
Purkinje cell degeneration beginning at 3 weeks of age 9. However, neither ataxia nor 
Purkinje cell degeneration was apparent in 9/10 F2 Aarssti/sti mice from a B6.Aarssti/+ and 
CAST/Ei (CAST) mating at 12–16 months old, suggesting that CAST-derived alleles could 
suppress neuron loss. In agreement, two phenotypically distinct classes of N1 Aarssti/sti 
offspring (generated from a backcross of F1 B6/CAST Aarssti/sti mice to B6.Aarssti/+ mice) 
were observed at equal frequencies: mice with ataxia and extensive Purkinje cell loss similar 
to that of B6.Aarssti/sti mice and mice without ataxia and little Purkinje cell loss (Extended 
Data Fig. 1a). Suppression of the neurodegenerative phenotype was observed in 50% of 
backcross mice from crosses to CASA/RkJ (CASA; a strain closely related to CAST/Ei), but 
not in other crosses, suggesting that a single dominant allele from the CAST or CASA 
strains can suppress sti-mediated neurodegeneration (Extended Data Fig. 1a).
Genome scans on affected and unaffected N1 Aarssti/sti mice revealed that the Purkinje cell 
degeneration was suppressed in mice that were heterozygous for CAST alleles on proximal 
Chromosome 2 (Extended Data Fig. 1b). This locus (~3.3Mbp) also segregated with the 
Aarssti/sti modifier gene from CASA, suggesting these strains share the same suppressor 
gene. Transfer of the Modifier of sticky (Msti) locus from the CAST genome onto the 
B6.Aarssti/sti genetic background rescued the decreased latency to fall in a rotorod test of 3-
month-old B6.Aarssti/sti mice and dramatically reduced Purkinje cell death, although some 
neurons in the rostral cerebellum of these mice still degenerated (Fig. 1a, 1b). 
Heterozygosity and homozygosity for CAST alleles in the Msti region similarly attenuated 
Purkinje cell loss, in agreement with the dominant nature of Msti (Fig. 1b).
Ubiquitin punctae characteristic of protein inclusions were observed in many Purkinje cells 
in 4-week-old B6.Aarssti/sti, but not in B6 or CAST, mice (data not shown). As expected due 
to progressive Purkinje cell loss observed in sti mutant mice, the number of Purkinje cells 
containing inclusions decreased by 6 and 12 weeks of age. However, very few Purkinje cells 
in B6.MstiCAST/B6; Aarssti/sti mice contained inclusions, even at later ages, confirming long-
term protection of Purkinje cells (Fig. 1c).
We further localized Msti to a 0.63 Mbp region and the coding regions of the protein-coding 
genes in this interval were amplified by RT-PCR from B6 and CAST cerebellar RNA and 
sequenced (Fig. 2a). Non-synonymous SNPs were observed in Il2rα, Fbxo18, and Ankrd16 
(Fig. 2a). However, with the exception of Il2rα, these SNPs were either not present in 
CASA, an Aarssti/sti modifying strain (Fbxo18), or were also present in MOLF (Ankrd16), a 
strain in which neurodegeneration is not rescued (Extended Data Fig. 1a and 1c).
A strain-specific Ankrd16 transcript that contained a 138 bp cryptic exon (exon 5’) was also 
observed in B6 (with or without the Aarssti/sti mutation) and other non-rescuing strains, but 
was absent in CAST or CASA (Fig. 2b, Extended Data Fig. 1d and e). Sequence analysis of 
intron 5 suggested that inclusion of this exon was due to a SNP that generated a novel 
alternative splice site (Fig. 2c, Extended Data Fig. 1f). Transcript levels of the correctly 
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spliced Ankrd16 isoform (lacking exon 5’) were 3.3 and 5.3 fold higher in the congenic 
MstiCAST/B6 or CAST cerebellum relative to B6, respectively (Fig. 2d). Protein levels were 
2.8 ± 0.2 and 3.9 ± 0.22 fold higher in the B6.MstiCAST/B6 and CAST cerebellum, 
respectively, and the Aarssti/sti mutation did not alter Ankrd16 splicing or protein levels (Fig. 
2e, Extended Data Fig 1e and g). Increased ANKRD16 levels were also observed in other 
tissues from MstiCAST/B6 mice (Extended Data Fig. 1h). The Ankrd16 transcript with exon 
5’ contains a premature stop codon and is predicted to undergo nonsense-mediated decay 
and in agreement, truncated forms of ANKRD16 were not observed (Fig. 2e, Extended Data 
Fig. 1g).
Neurodegeneration in Aarssti/sti mice was modified neither by transgenic expression of the 
CAST Il2rα cDNA nor deletion of Il2rα (data not shown). However, suppression of 
Aarssti/sti-mediated Purkinje cell loss was observed in mutant mice that carried a CAST BAC 
transgene containing the 3’portion of the Il15rα gene, and the Fbxo18 and Ankrd16 genes 
(Fig. 2f). However, another transgenic line (Tg25L9-19) generated with this BAC in which 
Ankrd16 was deleted upon integration was not able to suppress Purkinje cell degeneration 
(Fig. 2f, Extended Data Fig. 1i). Indeed, transgenic expression of the Ankrd16CAST coding 
sequence using the Purkinje cell-specific promoter Pcp2 in B6.Aarssti/sti mice suppressed the 
death of these neurons (Fig. 2g).
ANKRD16 binds AlaRS to reduce misincorporation of serine
ANKRD16 encodes a 39 kDa protein of unknown function that is composed of nine repeats 
of the ankyrin protein-protein interaction domain and is found only in vertebrates (Extended 
Data Fig. 2a, Extended Data Fig. 1j). To identify proteins that interact with ANKRD16, we 
transgenically expressed Ankrd16-myc under the control of the chicken beta-actin promoter 
and cytomegalovirus enhancer 15, 16. Co-immunoprecipitation (Co-IP) of ANKRD16 was 
performed using livers of transgenic and non-transgenic mice, and the immunoprecipitates 
were analyzed via tandem mass spectrometry (LC-MS/MS). Surprisingly, AlaRS was the 
most abundant protein after the ANKRD16 bait protein (Extended Data Fig. 2a). Interaction 
of ANKRD16 with wild type or mutant AlaRS in the liver and brain was confirmed by Co-
IP/western blotting (data not shown and Fig. 3a). Interactions between ANKRD16 and 
AlaRS were independent of both the epitope tag and bait protein (Extended Data Fig. 2b and 
c).
Co-IP experiments demonstrated that the AlaRS aminoacylation domain was efficiently co-
immunoprecipitated by ANKRD16, and little interaction was observed in the absence of this 
domain (Fig. 3b, Extended Data Fig. 2b). Affinity-capture experiments using purified AlaRS 
protein further defined that the AlaRS catalytic domain was sufficient for ANKRD16 
interaction and that this interaction was direct (Extended Data Fig. 2e, Fig. 3c). Furthermore, 
AlaRS did not Co-IP ANKRD29, a protein comprised of 8 ankyrin repeats (Extended Data 
Fig. 2d), nor did ANKRD16 interact with tyrosyl-tRNA synthetase or tryptophanyl-tRNA 
synthetase (Fig. 3c), suggesting a specific ANKRD16-AlaRS interaction with similar 
binding dynamics between AlaRSWT and AlaRSA734E (Extended Data Fig. 2f).
The AlaRSA734E mutation leads to increased death of Aarssti/sti embryonic fibroblasts when 
cultured with increasing concentrations of serine 9. MstiCAST/B6; Aarssti/sti fibroblasts were 
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more resistant than B6.Aarssti/sti fibroblasts to high serine concentrations, and at the highest 
concentrations (40 mM), less cell death was observed in MstiCAST/B6; Aarssti/sti than in B6 
(MstiB6/B6) fibroblasts demonstrating that Ankrd16 suppresses serine-mediated cell death in 
Aarssti/sti cells (Fig. 3d)
Although ANKRD16 is a vertebrate-specific gene, mammalian and E. coli AlaRS are highly 
conserved with ~67% similarity in the catalytic domain. Indeed, mouse ANKRD16 was able 
to affinity-capture E. coli AlaRS (Fig. 3c), and reduced death of E. coli with a severe editing 
domain mutation (C666A/Q584H) in AlaRS when grown on a serine gradient (Fig. 3e). 
Together, these results suggest that ANKRD16 influences AlaRS function.
Next, we used dipeptide formation on defined ribosome complexes as a read-out of charging 
and decoding fidelity. These experiments sufficiently detected serine mistranslation and 
AlaRS-mediated editing of Ser-tRNAAla (Extended Data Fig. 3a and b). When reactions 
using Ser-tRNAAla and AlaRS were supplemented with alanine, loss of fMet-Ser coincided 
with gain of fMet-Ala (Fig. 4a), consistent with reported post-transfer editing by AlaRS 7. 
However, no obvious differences were observed between reactions using AlaRSWT or 
AlaRSA734E, and ANKRD16 had no effect on either reaction in these experiments using 
mischarged tRNA.
In contrast, when deacyl tRNAAla, serine, and ATP were used, AlaRSA734E generated more 
fMet-Ser than AlaRSWT and ANKRD16 reduced the amount of this aberrant dipeptide in 
reactions with either AlaRSA734E or AlaRSWT (Extended Data Fig. 3c). Although 
ANKRD16 interacts with AlaRS1–455 (Extended Data Fig. 2f), no reduction in the amount 
of aberrant dipeptide was observed, implying the editing and/or C-terminal domains of 
AlaRS may contribute to ANKRD16 function. Furthermore, in the presence of ATP and a 
mixture of Ser and Ala, ANKRD16 specifically decreased fMet-Ser formation, thereby 
increasing AlaRSA734E fidelity (i.e., fMet-Ala/fMet-Ser) by a factor of ~20 (Fig. 4b). Thus, 
ANKRD16 acts prior to formation of mischarged tRNA to enhance translational fidelity.
In agreement, ANKRD16 had no effect on subsequent steps of tRNA mischarging including 
deacylation of mischarged Ser-tRNAAla, transfer of the mischarged tRNA to EF-Tu, or 
activation/aminoacylation of the cognate amino acid alanine (Extended Data Fig. 3d–g). In 
addition to post-transfer editing activity, in E. coli pre-transfer editing has also been 
observed in AlaRS 17. Serine-dependent ATPase activity was also observed with mouse 
AlaRSWT in the absence of tRNA (Extended Data Fig. 4a). However, this activity was 
decreased with both AlaRSA734E and AlaRS1–455 (Fig. 4c, Extended Data Fig. 4b). 
ANKRD16 was able to restore that activity for AlaRSA734E, but not for AlaRS1–455, further 
suggesting that the editing domain contributes to the serine-dependent ATPase activity 
and/or the modulation of this activity by ANKRD16 (Fig. 4c, Extended Data Fig. 4b and c).
Unexpectedly, ANKRD16 appeared to stimulate tRNA-dependent precipitation of 3H-serine 
but not of 3H-alanine in reactions with AlaRSA734E (Extended Data Fig. 4d–f). However, 
misactivated 3H-serine was also precipitated in reactions without tRNAAla with 
approximately three linked-serine adducts per ANKRD16 (Extended Data Fig. 4g). In 
contrast, 3H-alanine-adduct formation per ANKRD16 with AlaRSA734E, in the absence of 
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tRNAAla, was much lower (Extended Data Fig. 4h). Furthermore, in the presence of 
tRNAAla and AlaRSA734E, alanine linked to ANKRD16 was negligible relative to that 
coupled to tRNAAla (Fig. 4d).
These results suggest that ANKRD16 functions as an alternative to water or tRNAAla, 
accepting misactivated serine. Previous studies have demonstrated that reactive aminoacyl 
adenylates may react with cysteine or lysine residues 18, 19, 20, 21. Levels of precipitated 
serine were only slightly diminished after prolonged exposure to alkaline pH, which 
hydrolyzes thiol esters (e.g. cysteine). Thus, the ANKRD16 serine adduct is likely an amide 
(e.g. lysine) (Extended Data Fig. 4i).
To identify residues of ANKRD16 that accept misactivated serine, we utilized mass 
spectrometry. No spectral shift with Cys-containing peptides was observed. While not all 
Lys-containing peptides of ANKRD16 were resolved, highly conserved lysines - K102, 
K135, and K165 - shifted by 87 Da (the mass of serine) (Extended Data Fig. 1j, Extended 
Data Fig. 5a–d). Therefore, we mutated those Lys codons to Arg (ANKRD163xArg) 
(Extended Data Fig. 4g). Circular dichroism spectroscopy and thermal shift assays suggested 
that wild type and ANKRD163xArg have similar secondary structures and stabilities 
(Extended Data Fig. 5e and f), and only a slight change (~2 fold) in affinity for AlaRSA734E 
(Extended Data Fig. 2f and 5g). In contrast to ANKRD16, ANKRD163xArg had no effect on 
AlaRSA734E pre-transfer editing (Fig 4e, Extended Data Fig. 4b). Unlike ANKRD16, which 
rescued AlaRSC666A/Q584H. E. coli growth in high levels of serine, ANKRD163xArg did not 
rescue growth of mutant bacteria under these conditions (Fig. 4f). Similarly, serine-induced 
death of B6.Aarssti/sti embryonic fibroblasts was prevented by expression of Ankrd16, but 
not Ankrd163xArg (Fig. 4g, Extended Data Fig. 6). Accordingly, we generated a model for 
the ANKRD16-AlaRS complex (Fig. 4h). Modified lysine side chains of ANKRD16 project 
out from the helix-loop-helix motifs, with each in close proximity to the active site of 
AlaRS, where serine is misactivated.
Complete loss of Ankrd16 in Aarssti/sti mice leads to extensive neurodegeneration
To determine if the specificity of neuron death in Aarssti/sti mice is correlated with the 
ANKRD16 levels, we performed immunofluorescence. ANKRD16 was widely expressed in 
the brain and was detected in the nucleus as well as the cytoplasm (Fig. 5a, Extended Data 
Fig. 7a, b). Intriguingly, ANKRD16 levels were lower in Purkinje cells relative to cerebellar 
granule cells, cells of the cerebellar molecular layer, hippocampal neurons, and cells in the 
cortex (Fig. 5a).
To test if the levels of Ankrd16 influence the sensitivity of cells to the Aarssti/sti mutation, 
we generated an Ankrd16 null allele (Extended Data Fig. 7c, d). Ankrd16−/− mutant mice 
had no obvious pathologies in the brain or other organs, even when aged to 12 months (data 
not shown). However, loss of Ankrd16 in Aarssti/sti mice resulted in early embryonic 
lethality (Extended Data Fig. 7e). These results show that the low levels of ANKRD16 
present in B6 mice are sufficient to resolve sti-mediated editing defects induced during 
embryonic development.
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To determine the impact of decreasing ANKRD16 levels on neuronal cell survival we 
conditionally deleted Ankrd16 in postnatal Purkinje cells in Aarssti/sti mice. Purkinje cell 
loss in B6.Pcp2-Cre; Ankrd16fl/−; Aarssti/sti mice began at about 3 weeks of age; by 4 weeks 
of age, the majority of Purkinje cells were absent and in contrast to Aarssti/sti mice, all 
Purkinje cells had degenerated by 7 months of age (Extended Data Fig. 8a and Extended 
Data Fig. 9a). Formation of ubiquitin- and p62-positive aggregates was also accelerated in 
Purkinje cells with aggregates observed in 12.3% of Purkinje cells compared to 2.5% of 
these neurons in Aarssti/sti mice at 3-weeks of age (Extended Data Fig. 9a).
Deletion of Ankrd16 in the embryonic cerebellar primordium using En1-Cre 22 resulted in 
protein aggregates and neuron death in interneurons in the molecular layer and neurons in 
the granule cell layer in addition to Purkinje cells (Extended Data Fig. 8b, 8c, and 9b). 
Furthermore, loss of Ankrd16 in postnatal cortical and hippocampal neurons also caused 
their degeneration. Ubiquitin- and p62-positive aggregates were observed both in 
hippocampal pyramidal cells (2.80% ± 0.22%) and cortical neurons in 2-month-old 
B6.CaMKIIa-Cre; Ankrd16fl/−; Aarssti/sti mice (Fig. 5b–d, Extended Data Fig. 9c). Together, 
these data demonstrate that neurons other than Purkinje cells are also sensitive to the effects 
of mistranslation and further suggest that ANKRD16 protects against mistranslation in a 
dose-dependent fashion.
Discussion
In contrast to known editing mechanisms of tRNA synthetases or free-standing homologs of 
editing domains that act autonomously 23, 24, tRNA-independent hydrolysis of misactivated 
serine by AlaRS is enhanced through binding of ANKRD16 which captures misactivated 
serine and removes it from the pool for protein synthesis (Extended Data Fig. 10a and b). 
Unlike most tRNA synthetases, AlaRS not only misactivates smaller (glycine) but also larger 
(serine) amino acids than alanine due to structural properties that make it difficult for AlaRS 
to exclude misactivated serine 2, 24, 25, 26, 27. Thus, serine misactivation by AlaRS, and the 
toxic effects of Ser-for-Ala replacements in vertebrates, may present a special situation in 
which an editing co-factor is necessary for proofreading.
In addition to providing direct mechanistic insights into editing functions of aminoacyl 
tRNA synthetases, the discovery of Ankrd16 highlights the importance of studing mRNA 
translation in higher organism and may provide understanding for the cell-type sensitivity of 
phenotypes associated with the Aarssti mutation. More broadly, cell-type selectivity resulting 
from “monogenic” mutations in ubiquitous genes has been difficult to resolve. Only a few 
modifier genes of disease mutations have been identified in an unbiased approach and these 
suggest that modifier genes may function in independent, parallel pathways 28, 29, 30. Our 
identification of Ankrd16 as a modifier of the Aarssti mutation demonstrates that this 
possibility may be an oversimplification and that restricted pathologies may be due to the 
expression levels of genes that modify the function of the gene harboring the primary 
mutation.
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Extended Data
Extended Data Figure 1. Identification of Ankrd16 as a genetic modifier of the B6J.Aarssti/sti 
mutation
a, 3- to 4-month-old Aarssti/sti mice from crosses to inbred strains. b, Location of Msti 
relative to microsatellite markers. Centimorgan (cM), megabase pairs (Mbp). c, 
Nonsynonymous SNPs in Msti candidate genes. The amino acids and position are shown at 
the top of the table with the B6 residue listed first. d, RT-PCR analysis of Ankrd16 
transcripts from cerebellar cDNA prepared from C57BL/6J and CAST/Ei mice. Note, the 
alternative Ankrd16 transcript containing exon 5’ (see Figure 2c) amplified by primers to 
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exon4/6 or exon 5/7 was present in cDNA from C57BL/6J but not CAST/Ei mice, whereas 
the alternative transcript detected by exon1/3 primers was present in cDNA from both 
strains. e, RT-PCR analysis of Ankrd16 transcripts from cerebellar cDNA prepared from 
C57BL/6J, CAST/Ei, Aarssti/sti, and MstiCAST/CAST; Aarssti/sti mice. Note, the alternative 
Ankrd16 transcript containing exon 5’ (see Figure 2c) amplified by exon 5/7 or 3/5’ primers 
was present in cDNA from C57BL/6J and Aarssti/sti, but absent in the presence of CAST/Ei 
derived Msti (CAST/Ei and MstiCAST/CAST; Aarssti/sti mice). f, Sequence of the SNP-
containing region in intron 5 of Ankrd16. Capital letters indicate novel exon 5’ and lower 
case letters indicate intron 5. The SNP in non-rescuing strains is shown in red. g, Western 
blotting analysis of ANKRD16 from cerebellar lysates. Note that the expression of 
ANKRD16 is reduced in C57BL/6J and Aarssti/sti mice relative to mice with CAST/Ei 
derived Msti (CAST/Ei and MstiCAST/CAST; Aarssti/sti mice) (mean ± SD, n = 3, One-way 
ANOVA (Tukey correction), **** p ≤ 0.0001). h, Protein levels of AlaRS and ANKRD16 
were determined by western blotting using various mouse tissues from C57BL/6J and B6 
congenic mice heterozygous for the Msti region (MstiCAST/B6). GAPDH is included as a 
loading control. Note the increase in ANKRD16 levels in MstiCAST/B6 tissues, whereas 
AlaRS levels do not change between genotypes. i, PCR results of genomic DNA from B6 
transgenic mouse lines Tg25L9-19 and Tg25L9-46, which carry the CAST/Ei BAC. 
Polymorphic markers, which differentiate between C57BL/6J and CAST/Ei were used as 
shown. j, Amino acid sequence comparison of ANKRD16 from various species with the 
C57BL/6J strain shown. Non-synonymous SNPs distinguishing CAST/Ei and C57BL/6J are 
shown in yellow and serinylated lysines are shown in red.
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Extended Data Figure 2. Verification of interaction between ANKRD16 and AlaRS in vitro
a, Peptide/spectral counts of proteins co-immunoprecipitated (Co-IP) from transgenic 
Ankrd16-myc (see cartoon) but not detected in non-transgenic liver tissue. b, HEK293T 
cells were transiently co-transfected with myc-tagged constructs for mouse Aars, AarsA734E, 
the Aars aminoacylation domain (AAD), and FLAG-tagged Ankrd16. Co-IP experiments 
were performed with ANKRD16-FLAG as the bait protein. c, Reciprocal Co-IP experiments 
were performed by transiently co-transfecting HEK293T cells with HA-tagged constructs 
for mouse Aars or AarsA734E and the FLAG-tagged Ankrd16. HA-AlaRS proteins were used 
as bait for pull down. d, Domain structure of mouse ANKRD16 and ANKRD29. HEK293T 
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cells were transiently transfected with FLAG-tagged constructs for mouse Ankrd16, 
Ankrd29, and the HA-epitope tagged Aars. Co-IP experiments were performed with HA-
AlaRS as bait protein. e, Various domain protein products of AlaRS (human) as indicated 
were bacterially expressed, purified, and incubated with GST-ANKRD16. GST-pull down 
products and input were immunoblotted with anti-His or -GST antibodies. Asterisks indicate 
protein degradation products. f, Binding dynamics were determined between mouse wild 
type or mutant AlaRS and mouse wild type or mutant ANKRD16 using SwitchSENSE 
(mean ± SD; n = 3).
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Extended Data Figure 3. Analysis of the effects of ANKRD16 on steps of translation
a, Preassembled ternary complex containing either Ser-tRNAAla or Ala-tRNAAla was mixed 
with 70S initiation complex (IC) programmed with codon GCU in the A site, aliquots were 
transferred at various times to quench solution (0.5 M KOH), and products were resolved by 
eTLC. b, Incubation of full-length AlaRS with preassembled EF-Tu•GTP•Ser-tRNAAla 
prevents fMet-Ser formation. EF-Tu•GTP•Ser-tRNAAla ternary complex and 70S IC were 
each preassembled. In reaction scheme 1, AlaRS was incubated with EF-Tu•GTP•Ser-
tRNAAla for 15 min, 70S IC was added, and aliquots were removed at various times for 
eTLC analysis. In contrast (reaction scheme 2), AlaRS was incubated with the 70S IC for 15 
min, followed by addition of EF-Tu•GTP•Ser-tRNAAla, and aliquots were removed at 
various times for eTLC analysis. c, Deacylated tRNAAla was mixed with AlaRS, serine, 
ATP, and all other components to form ternary complex, aliquots were transferred at various 
time points to the 70S IC, and dipeptide products were resolved by eTLC. t = 0 (control 
reactions in the absence of AlaRS); * (oxidized fMet). Note, without alanine 
supplementation (b and c), trace amounts of fMet-Ala are detected, likely due to AlaRS-
bound alanyl-AMP during protein purification. d, Deacylation of [3H]Ser-tRNAAla by 
mouse wild-type AlaRS or AlaRSA734E in the presence or absence of ANKRD16 (mean ± 
SD, n = 2, One Phase Decay model [R2AlaRSWT = 0.9892; R2AlaRSA734E = 0.991; 
R2AlaRSWT/ANKRD16 = 0.9872; R2AlaRSA734E/ANKRD16 = 0.9902; R2ANKRD163xArg = 
0.7992]). e, Percentage of EF-Tu retained on filter membrane upon addition of various 
components as indicated (mean ± SD; n = 2). f, ATP-pyrophosphate exchange by mouse 
AlaRSA734E in the presence or absence of ANKRD16 (mean ± SD, n = 2, Michaelis-Menten 
model [R2AlaRSA734E = 0.9763; R2AlaRSA734E/ANKRD16 = 0.9874]). g, Aminoacylation of 
tRNAAla with alanine by mouse AlaRSA734E in the presence or absence of ANKRD16 
(mean ± SD, n = 2, Michaelis-Menten model [R2AlaRSA734E = 0.9879; 
R2AlaRSA734E/ANKRD16 = 0.9846]).
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Extended Data Figure 4. Analysis of serinylation of ANKRD16
a, tRNA-independent ATPase activity of mouse wild type AlaRS for serine or alanine (mean 
± SD, n = 3, Michaelis-Menten model [R2Ser = 0.9926; R2Ala = 0.8430]). b, tRNA-
independent ATPase activity of mouse AlaRSWT or AlaRSA734E for serine in the presence of 
ANKRD16, ANKRD29, or ANKRD163xArg (mean ± SD, Michaelis-Menten model 
[R2AlaRSWT = 0.9926, R2AlaRSA734E = 0.9899, R2AlaRSA734E/ANKRD16 = 0.9918, 
R2AlaRSA734E/ANKRD29 = 0.9939, R2AlaRSA734E/ANKRD163xArg = 0.9841], [AlaRSWT, 
AlaRSA734E, AlaRSA734E/ANKRD29, n = 3], [AlaRSA734E/ANKRD16, AlaRSA734E/
ANKRD163xArg, n = 4]). c, TLC analysis of ATPase activity of AlaRSA734E against serine 
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in the absence and presence of ANKRD16. d, Experimental scheme showing how data were 
generated for panels e, f, g, and h. e, Acylation reactions with radioactive alanine were 
performed as above to determine alanine transfer (mean ± SD, n = 2, Michaelis-Menten 
model [R2AlaRSA734E/tRNA/ANKRD16 = 0.9611, R2AlaRSA734E/tRNA/buffer = 0.9641]). f, 
Misacylation of tRNAAla with radioactive serine by mouse AlaRSA734E in the presence or 
absence (buffer) of ANKRD16. After misacylation, reactions were subjected to TCA 
precipitation of RNA (Ser-tRNAAla) and protein under acidic conditions to maintain Ser-
tRNA (mean ± SD, n = 2, Michaelis-Menten model [R2AlaRSA734E/tRNA/ANKRD16 = 0.9577, 
R2AlaRSA734E/tRNA/buffer = 0.7841]). g, Misacylation reactions using radioactive serine and 
mouse AlaRSWT or AlaRSA734E were performed in the presence or absence of ANKRD16, 
ANKRD29, ANKRD163xArg, or tRNAAla. After TCA precipitation under neutral pH 
conditions, serine was measured (mean ± SD, n = 4). Note, the higher level of TCA-
precipitated serine on tRNA or protein in the presence of ANKRD16. h, Acylation reactions 
using radioactive alanine and mouse AlaRSA734E were performed in the presence or absence 
of ANKRD16 or tRNAAla. After TCA precipitation under neutral pH conditions, alanine 
was measured (mean ± SD, n = 4). i, Misacylation reactions using radioactive serine and 
mouse AlaRSA734E were performed in the presence of ANKRD16 either with or without 
tRNAAla. Reactions were treated with or without Na2CO3 (final concentration of 0.15 M 
[alkaline pH]) for 30 minutes, followed by TCA precipitation. Precipitated [3H]-serine-links 
were measured and plotted as relative level of serinylation (mean, n = 2).
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Extended Data Figure 5. Analysis of serinylation of ANKRD16 by mass spectrometry
a, MS/MS spectrum of peptides from ANKRD16. Incorporation of serine onto ANKRD16 
was observed when serine was misactivated by mouse AlaRSA734E (+ATP). Misactivation 
was not observed in the absence of ATP. MS/MS spectrum of peptides from ANKRD16 with 
serine linked to positions K102 (b), K135 (c) and K165 (d). a ions [a], b ions [b] and y ions 
[y] are annotated in green, red, and purple, respectively. The triply charged precursor had a 
mass of 2153.065 Dalton and included carbamidomethyl cysteine. e, Secondary structure 
analysis of mouse ANKRD16 and ANKRD163xArg. Far-UV circular dichroism (CD) spectra 
of wild type ANKRD16 (blue) and ANKRD163xArg (red) show highly similar CD spectra 
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(mean ± SD, n = 4). f, Thermal shift analysis of mouse ANKRD16 (blue) and 
ANKRD163xArg (red) show highly similar thermal stability. g, HEK293T cells were 
transiently co-transfected with myc-tagged constructs for mouse AarsA734E and FLAG-
tagged Ankrd16, Ankrd163xArg, or Ankrd29. Co-IP experiments were performed with 
FLAG-tagged proteins as the bait protein. Binding affinity was determined by normalizing 
immunoprecipitation (IP) signal of AlaRSA734E to the input signal, in which the interaction 
of AlaRSA734E/ANKRD16 was arbitrarily defined as 1 to determine relative binding affinity 
of AlaRSA734E/ANKRD163xArg (mean ± SD, n = 3).
Extended Data Figure 6. Serine-induced cell death in Aarssti/sti fibroblasts
B6.Aarssti/sti embryonic fibroblasts were co-transfected with hrGFP (humanized 
recombinant GFP, green) and either Ankrd16-Flag or Ankrd163xArg-Flag (n = 4). 12-hours 
post-transfection, serine was added and cells were cultured for 24 hours prior to staining 
with propidium iodide (PI) (red) and Hoechst (blue) to determine cell death. Arrowheads 
represent PI-positive GFP+ cells. Scale bars: 100 µm.
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Extended Data Figure 7. Analysis of ubiquitous deletion of ANKRD16
a, Protein levels of ANKRD16 were determined by western blotting of tissues from B6 mice 
homozygous for the Msti region (MstiCAST/CAST). b, Subcellular analysis of ANKRD16 and 
AlaRS via cell fractionation of brains from B6.MstiCAST/B6 and Ankrd16−/− mice. Cellular 
fractions were confirmed using antibodies for histone 3 (nuclear marker), GAPDH (cytosolic 
marker), COX IV (mitochondrial marker), GRP78 (ER marker), and Sec61 beta (rough ER 
marker). c, To generate a ubiquitous or conditional loss-of-function allele, loxP sites that 
flank exon 2 of Ankrd16 were inserted by homologous recombination. Removal of exon 2 
results in a frame shift and premature stop codon in exon 3. Ankrd16 was ubiquitously 
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deleted by EIIa Cre-mediated removal of exon 2 and the neo cassette. Flp-mediated excision 
of the neomycin cassette was utilized to generate a conditional loss-of-function Ankrd16 
allele. d, Loss of ANKRD16 was verified by western blotting. Protein extracts from 
Ankrd16−/−, MstiCAST/CAST and C57BL/6J mice were used for comparison purposes and 
GAPDH was used as a loading control. e, The number of embryos or mice of various 
genotypes from intercrosses of Aarssti/+; Ankrd16−/− mice over the total number observed. 
Representative images of E9.5 embryos. Note, Aarssti/sti; Ankrd16−/− embryos are smaller 
and have failed to turn. Abbreviations: embryonic day (E), postnatal day (P). Scale bars: 500 
µm.
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Extended Data Figure 8. Conditional deletion of Ankrd16 accelerates Purkinje cell loss and 
causes widespread neurodegeneration in the B6.Aarssti/sti cerebellum
a and b, Calbindin D-28 immunohistochemistry of sagittal cerebellar sections. c, Cresyl 
violet-stained sagittal cerebellar sections. Note, the presence of interneurons in the ML of 
B6.Aarssti/sti cerebellum despite the thinning of the ML as a consequence of Purkinje cell 
degeneration. In contrast, loss of Ankrd16 in the B6.Aarssti/sti cerebellum results in 
degeneration of ML interneurons. Scale bars: 500 µm (a, b, c), 50 µm (c, higher 
magnification). Abbreviations: postnatal day (P), molecular layer (ML), Purkinje cell layer 
(PL), granule cell layer (GL).
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Extended Data Figure 9. Conditional deletion of Ankrd16 accelerates formation of protein 
aggregates in B6.Aarssti/sti mice
a, Ubiquitin (red), p62 (green), and Calbindin D-28 (blue) immunofluorescence on sagittal 
cerebellar sections. The percentage of aggregate-positive Purkinje cells and Purkinje cells 
are shown (mean ± SD, n = 3, Multiple t-tests (Holm-Sidak method), *** p = 0.0002466 
(Purkinje cells with aggregates, P21), p = 0.0002336 (Purkinje cells with aggregates, P28), p 
= 0.0003214 (percent of Purkinje cells, P21), **** p = 7.701787×10−5 (percent of Purkinje 
cells, P28)). Note, the percent of Purkinje cells is relative to control C57BL/6J mice. b, Cell 
type-specific markers (red), and p62 (green) immunofluorescence on sagittal cerebellar 
sections. Parvalbumin (Parv) was utilized to identify Purkinje cells and interneurons (stellate 
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and basket cells) in the ML. NeuN was utilized to distinguish between granule and Golgi 
cells in the GL. (En1-Cre; Ankrd16fl/−; Aarssti/sti: Golgi cell [closed arrow head, p62+/NeuN
−]; granule cell [arrow, p62+/NeuN+]; basket/stellate cell [open arrow head, p62+/Parv+]). c, 
Ubiquitin (red) and p62 (green) immunofluorescence on sagittal sections of the cortex (layer 
IV). Scale bars: 10 µm (a), 50 µm (b and c, low magnification) and 10 µm (b and c, higher 
magnification). Abbreviations: postnatal day (P), molecular layer (ML), Purkinje cell layer 
(PL), granule cell layer (GL).
Extended Data Figure 10. Model for the role of ANKRD16 in translational fidelity
a, A point mutation in the editing domain of AlaRS (A734E) results in editing defects, as 
indicated by deficits in tRNA-independent ATPase activity, which in turn leads to increased 
levels of incorrectly aminoacylated Ser-tRNAAla, misincorporation of serine during 
translation, protein aggregation, and cell death. b, Interaction of ANKRD16 with the 
aminoacylation domain of editing-deficient AlaRSA734E stimulates tRNA-independent 
editing and misactivated serines are transferred onto ANKRD16. Mitigation of serine 
misactivation prevents sti-mediated mistranslation, and thereby prevents protein aggregation 
and cell death.
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Figure 1. Modifier of sticky (Msti) suppresses Aarssti-mediated neurodegeneration
a, Rotorod analysis of 3-month-old mice (mean ± SD, n = 15 or 16 mice/genotype, Two-way 
ANOVA (Tukey correction), ** p ≤ 0.01, *** p ≤ 0.001). b, Calbindin D-28 
immunohistochemistry. Sections were counterstained with hematoxylin. c, Aggregate-
positive cells (mean ± SD, n = 3, Multiple t-tests (Holm-Sidak method), ** p = 0.00148 (6 
weeks), p = 0.00498 (12 weeks), **** p = 2.819×10−6). Scale bars: 500 µm.
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Figure 2. Ankrd16 is the modifier of Aarssti/sti
a, Amino acid polymorphisms between C57BL/6J and CAST/Ei in Msti region. b, 
Alternative splicing of Ankrd16 in the cerebellum. c, An intronic SNP (red) introduces a 
cryptic exon (exon 5’) in Ankrd6 in non-Msti containing strains. d, Expression of correctly 
spliced Ankrd16 in the cerebellum (mean ± SEM, n = 3, One-way ANOVA (Tukey 
correction), * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001). e, Western blot analysis using cerebellar 
extracts. f and g, Calbindin D-28 immunohistochemistry. Scale bars: 500 µm.
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Figure 3. ANKRD16 interacts with AlaRS and prevents serine-mediated cell death
a, AlaRS/ANKRD16 interaction in the brain. b, Co-IP experiments in HEK293T cells using 
mouse myc-AlaRS domain constructs. c, Pull down of purified AlaRS, TyrRS, or TrpRS 
with ANKRD16. d, Cell death of embryonic fibroblasts (mean ± SD, n = 3, Two-way 
ANOVA (Tukey correction), *** p ≤ 0.001; **** p ≤ 0.0001). e, AarsC666A/Q584H E. coli 
expressing mouse Ankrd16 or Ankrd29.
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Figure 4. ANKRD16 enhances tRNA-independent editing and accepts serine adenylates from 
AlaRS
a, Mouse AlaRS (±ANKRD16) was added to reactions containing Ser-tRNAAla and alanine. 
b, Mouse AlaRS (±ANKRD16) was added to reactions containing deacylated tRNAAla, 
alanine and serine (* oxidized fMet). c, Ser-AMP hydrolysis at 10 min (mean ± SD, n = 3, 
One-way ANOVA (Tukey correction), *** p ≤ 0.001, **** p ≤ 0.0001). d, Ratio of alanine- 
or serine-linked ANKRD16/aminoacylated tRNAAla (mean ± SD, n = 3, Two-tailed 
Student’s t-test, ** p = 0.0011). e, Ser-AMP hydrolysis at 10 min (mean ± SD, n = 3, One-
way ANOVA (Tukey correction), *** p ≤ 0.001). Control reactions from panel c (†). f, 
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AarsC666A/Q584H E. coli expressing mouse Ankrd16 or Ankrd163xArg. g, Cell death of 
embryonic fibroblasts (mean ± SEM, n = 4, One-way ANOVA (Tukey correction), *** p ≤ 
0.001, **** p ≤ 0.0001). h, Structural model of ANKRD16 and the aminoacylation domain 
(AAD) of AlaRS, modified lysines (purple), active site residues (orange), and Ala-AMS 
(Ala-AMP analog, green).
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Figure 5. Loss of Ankrd16 in Aarssti/sti mice causes protein aggregation and neurodegeneration
a and b, Immunofluorescence with antibodies to ANKRD16 (green) and calbindin D-28 
(red) or ubiquitin (red) and p62 (green). c and d, Cresyl violet staining of hippocampus (c) 
and cortex (d). Scale bars: 50 µm (a, low magnification), 10 µm (a, higher magnification), 
50 µm (b, low magnification), 10 µm (b, higher magnification), 500 µm (c, low 
magnification), 50 µm (c, higher magnification), 100 µm (d). Postnatal day (P), Cornu 
Ammonis (CA), Dentate gyrus (DG).
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